Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;78:848-856

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanda, T.
Right arrow Articles by Kobayashi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanda, T.
Right arrow Articles by Kobayashi, I.
(Circulation Research. 1996;78:848-856.)
© 1996 American Heart Association, Inc.


Articles

Modification of Viral Myocarditis in Mice by Interleukin-6

Tsugiyasu Kanda, Janet E. Wilson McManus, Ryozo Nagai, Susumu Imai, Tadashi Suzuki, DeCheng Yang, Bruce M. McManus, Isao Kobayashi

From the Department of Laboratory Medicine (T.K., I.K.) and the Second Department of Internal Medicine (R.N., S.I.), Gunma University School of Medicine, and the College of Medical Care and Technology (T.S.), Gunma University, Maebashi, Japan, and the Department of Pathology and Laboratory Medicine (J.E.W.M., D.Y., B.M.M.), University of British Columbia, St. Paul's Hospital, Vancouver, Canada.

Correspondence to Tsugiyasu Kanda, MD, Department of Laboratory Medicine, Gunma University School of Medicine, 3-39-15, Showa-machi, Maebashi 371, Japan.

Abstract Inflammatory cytokines play a key role in the myocardial injury produced by viral myocarditis. Although interleukin-6 (IL-6) reportedly possesses antiviral properties, its effect in viral myocarditis is unclear. To investigate the role of IL-6 in viral myocarditis induced by encephalomyocarditis virus (EMCV) in mice, we evaluated (1) the survival rate following IL-6 administration, (2) the viral titer in the heart, (3) viral replication in the heart by in situ hybridization, (4) histopathological changes using immunohistochemical staining, (5) neutralizing antibody against EMCV, (6) circulating interferon and tumor necrosis factor-{alpha} (TNF-{alpha}), (7) viral suppression in vitro by IL-6, and (8) natural killer (NK)–cell activity. Eight-week-old C3H/HeJ mice were injected intraperitoneally with EMCV (day 0) and were also injected subcutaneously twice daily for 4 consecutive days with 10 µg/0.1 mL of human IL-6 on day -4 (group A), day 0 (group B), or day +4 (group D) for 4 days. As a control, 0.1 mL PBS instead of IL-6 was injected on day 0 for 4 days (group C). Certain mice were killed on day 4. The myocardial virus titers, viral replication in situ, and NK-cell activity in the spleen were determined. Decreased viral titer and viral replication in the heart reduced the titer of circulating TNF-{alpha}, and lower NK-cell activity was observed in group B versus group C (control group). The titer of neutralizing antibodies against EMCV was significantly (P<.05) increased in group B compared with group C. The remaining mice were killed on days 10 and 30 after infection. The ratio of heart weight (HW) to body weight (BW) and myocardial injury in group B were reduced versus group C on days 10 and 30. The HW of group B on day 30 did not differ from the normal control group. The ratio of splenic weight to BW and the ratio of thymic weight to BW of group B increased on day 10, with expanded follicles observed in the spleen and enlargement of the medulla observed in the thymus. Immunohistochemical study revealed an increased percentage of macrophages in the heart and spleen of group B. In summary, IL-6 reduces myocardial damage in mice with viral myocarditis. Modification of immune responses together with reduction in viral replication appears to be the mechanism of the IL-6 effect. Although IL-6 is likely important in the process of viral antigen presentation, early activation of immune responses and attenuation of viral replication appear most significant, as reflected in the limited time window during which IL-6 is effective in myocarditis.


Key Words: myocarditis • interleukin-6 • host immunity • in situ hybridization




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
Z. Shijie, J. Moriya, J. Yamakawa, R. Chen, T. Takahashi, H. Sumino, T. Nakahashi, K. Iwai, S. Morimoto, N. Yamaguchi, et al.
Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis
Evid. Based Complement. Altern. Med., February 24, 2008; (2008) nen010v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. S. Hardarson, J. S. Baker, Z. Yang, E. Purevjav, C.-H. Huang, L. Alexopoulou, N. Li, R. A. Flavell, N. E. Bowles, and J. G. Vallejo
Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H251 - H258.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. Takahashi, F. Yu, S.-j. Zhu, J. Moriya, H. Sumino, S. Morimoto, N. Yamaguchi, and T. Kanda
Beneficial effect of brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome.
Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 109 - 115.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C.-T. Shun, S.-Y. Lu, C.-Y. Yeh, C.-P. Chiang, J.-S. Chia, and J.-Y. Chen
Glucosyltransferases of Viridans Streptococci Are Modulins of Interleukin-6 Induction in Infective Endocarditis
Infect. Immun., June 1, 2005; 73(6): 3261 - 3270.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. D. Prabhu
Cytokine-Induced Modulation of Cardiac Function
Circ. Res., December 10, 2004; 95(12): 1140 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. Lin, P.-Y. Shu, C. Chang, A.-K. Ng, and C.-p. Hu
IL-4 Suppresses the Expression and the Replication of Hepatitis B Virus in the Hepatocellular Carcinoma Cell Line Hep3B
J. Immunol., November 1, 2003; 171(9): 4708 - 4716.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. D. Pavelko, C. L. Howe, K. M. Drescher, J. D. Gamez, A. J. Johnson, T. Wei, R. M. Ransohoff, and M. Rodriguez
Interleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury
J. Neurosci., January 15, 2003; 23(2): 481 - 492.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Wada, K. Saito, T. Kanda, I. Kobayashi, H. Fujii, S. Fujigaki, N. Maekawa, H. Takatsu, H. Fujiwara, K. Sekikawa, et al.
Tumor Necrosis Factor-{{alpha}} (TNF-{{alpha}}) Plays a Protective Role in Acute Viral Myocarditis in Mice : A Study Using Mice Lacking TNF-{{alpha}}
Circulation, February 6, 2001; 103(5): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Kishimoto, H. Kawamata, S. Sakai, H. Shinohara, and H. Ochiai
Enhanced Production of Macrophage Inflammatory Protein 2 (MIP-2) by In Vitro and In Vivo Infections with Encephalomyocarditis Virus and Modulation of Myocarditis with an Antibody against MIP-2
J. Virol., February 1, 2001; 75(3): 1294 - 1300.
[Abstract] [Full Text]


Home page
JNMHome page
T. Iwasaki, T. Iwasaki, Y. Aihara, T. Kanda, N. Oriuchi, K. Endo, H. Katoh, T. Suzuki, and R. Nagai
Immunoscintigraphy of Aortic Dissection with 99mTc-Labeled Murine Anti-Smooth Muscle Myosin Monoclonal Antibody in Rats
J. Nucl. Med., January 1, 2001; 42(1): 130 - 137.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Heim, S. Zeuke, S. Weiss, W. Ruschewski, and I. M. Grumbach
Transient Induction of Cytokine Production in Human Myocardial Fibroblasts by Coxsackievirus B3
Circ. Res., April 14, 2000; 86(7): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Matsui, Y. Ihara, Y. Fujio, K. Kunisada, S. Akira, T. Kishimoto, and K. Yamauchi-Takihara
Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-{kappa}B and NF-IL6 in cardiac myocytes
Cardiovasc Res, April 1, 1999; 42(1): 104 - 112.
[Abstract] [Full Text] [PDF]